Manhattan Scientifics (Manhattan Scientifics) YoY EBITDA Growth : 100.00% (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Manhattan Scientifics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Manhattan Scientifics's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 100.00%.

Manhattan Scientifics's EBITDA per Share for the three months ended in Dec. 2023 was $0.00.

Manhattan Scientifics YoY EBITDA Growth Historical Data

The historical data trend for Manhattan Scientifics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Manhattan Scientifics YoY EBITDA Growth Chart

Manhattan Scientifics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

85.71

450.00

-185.71

16.67

60.00

Manhattan Scientifics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-	-	100.00	-	100.00

Manhattan Scientifics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Manhattan Scientifics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.002	-	-0.005)	/	\| -0.005 \|
=	60.00 %

Manhattan Scientifics's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0	-	-0.001)	/	\| -0.001 \|
=	100.00 %

Manhattan Scientifics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Manhattan Scientifics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Manhattan Scientifics (Manhattan Scientifics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Manhattan Scientifics Inc (OTCPK:MHTX) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

244 Fifth Avenue, Suite 2341, New York, NY, USA, 10001

Website

http://www.mhtx.com

Manhattan Scientifics Inc is a company operating as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in the areas of nano-technologies and nano-medicines. The company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. The company is focused on technology transfer and commercialization of transformative technologies.

Executives

Chris Theoharis	director	405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Photios Frank Georgiou	director	405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Emmanuel Tsoupanarias	director, officer: Chief Executive Officer	405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Leonard Friedman	director	405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Marvin Maslow	director, 10 percent owner, officer: Chief Executive Office	MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022
David Teich	director, officer: Treasurer	MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022
Ralph Anderson	director	641 FIFTH AVENUE SUITE 36F, NEW YORK NY 10022
Larry H Schatz	director	152 W. 57TH STREET, 31ST FLOOR, NEW YORK NY 10019
Marty Steinberg	10 percent owner	1111 BRICKELL AVENUE SUITE 2500, MIAMI FL 33131
Scott Bach	director, officer: Secretary	MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022

Manhattan Scientifics (Manhattan Scientifics) Headlines

No Headlines